Interestingly, the combined expression of CMTM6 and vimentin (95% CI 0.826–3.908; P = 0.040) was identified as an independent prognostic factor for OS (Table 2) in patients with HCC. This evidence concerns the gene VIM and hepatocellular carcinoma.